Walter Doty
Internal Medicine · Dothan, ALNPI 1932151719
Payments from drug & device makers
Across 119 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$683
- AbbVie$343
- Electromed, Inc.$216
- Novo Nordisk$120
- Abbott$110
- Pfizer$51
- plus $419 from 19 others
What the payments were for
- Food & beverage$1,87997%
- Education$121%
- Other$523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 33 | $683 |
| AbbVie(2 entities) | 17 | $343 |
| Electromed, Inc. | 18 | $216 |
| Novo Nordisk | 15 | $120 |
| Abbott | 9 | $110 |
| Pfizer | 3 | $51 |
| Gilead | 2 | $46 |
| Corcept Therapeutics | 3 | $41 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Ascendis Pharma Endocrinology Inc | 1 | $30 |
| Welch Allyn | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Intuitive Surgical | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Harmony Biosciences LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Medtronic | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Veran Medical Technologies, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVYCAZ$125
How this compares
$1,943 in reported general payments places this provider in the 70th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $21,976 |
| OzempicSemaglutide | 13 | $16,029 |
| EntrestoSacubitril/Valsartan | 18 | $13,185 |
| TrulicityDulaglutide | 11 | $12,344 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $9,872 |
| EliquisApixaban | 14 | $9,419 |
| Duloxetine Hcl | 47 | $1,375 |
| Levothyroxine Sodium | 108 | $1,255 |
| Potassium Chloride | 66 | $1,200 |
| Pantoprazole Sodium | 112 | $1,161 |
| Ezetimibe | 60 | $1,158 |
| Atorvastatin Calcium | 86 | $1,106 |
| Omeprazole | 70 | $1,026 |
| Hydroxychloroquine Sulfate | 11 | $1,016 |
| Metoprolol Succinate | 69 | $957 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $37 | $21,97621 claims |
| Novo NordiskOzempic | $120 | $16,02913 claims |
| Lilly USA, LLCTrulicity | $14 | $12,34411 claims |
| GSKTrelegy Ellipta | $683 | $9,87216 claims |
| PfizerEliquis | $51 | $9,41914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Dothan
- Donavon WewersDothan$1.3M
- Justin HoveyDothan$67K
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- Barry McLeanHomewood$4M
- William KirbyBirmingham$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.